Breast Cancer
Conditions
Brief summary
There is evidence that mindfulness-based interventions (MBIs) such as meditation, mindfulness-based stress reduction (MBSR) and yoga might improve Quality of Life (QOL) and reduce stress in breast cancer survivors. These interventions are becoming increasingly popular in cancer survivors. However, little is known about the feasibility and effect of MBIs administered during the interval of time of chemotherapy, on QOL and stress. The investigators are planning a MBI intervention study developed specifically for breast cancer survivors receiving chemotherapy (usually 4-5 months) at the investigators institution, for at least 8 sessions combined with at least 8 weeks of home-practice, in 25 women receiving chemotherapy for breast cancer.
Interventions
BEHAVIORALMindfulness
Meditation, body scan, yoga.
Sponsors
Mayo Clinic
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
20 Years to 75 Years
Healthy volunteers
Yes
Inclusion criteria
* Women 20-75 years old * Diagnosed with breast cancer * Scheduled to begin chemotherapy at Mayo Clinic Rochester
Exclusion criteria
* Pregnant * Practicing mindfulness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility - percentage of patients recruited from those approached, percentage of patients who dropped off, percentage of patients who are compliant (attending more than 75% of recommended sessions) | While receiving chemotherapy (usually 4-5 months) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Stress - measured by the Perceived Stress Scale - statistically and clinically significant reductions in stress | 7-8 months | Stress will be measured before the start of chemotherapy, monthly while receiving chemotherapy (usually 4-5 months) and at 3 months after chemotherapy |
Other
| Measure | Time frame | Description |
|---|---|---|
| Fatigue - Multidimensional Fatigue Symptom Inventory -Short Form statistically and clinically significant reductions in fatigue score | 7-8 months | Fatigue will be measured by the before the start of chemotherapy, monthly while receiving chemotherapy (usually 4-5 months) and at 3 months after chemotherapy |
| Quality of life measured by the Functional Assessment of Cancer Therapy - Breast - statistically and clinically significant improvement in quality of life | 7-8 months | Quality of life will be measured before the start of chemotherapy, monthly while receiving chemotherapy (usually 4-5 months) and at 3 months after chemotherapy |
| Sleep measured by the Pittsburgh Sleep Quality Index -statistically and clinically significant improvements in sleep | 7-8 months | Sleep will be measured before the start of chemotherapy, monthly while receiving chemotherapy (usually 4-5 months) and at 3 months after chemotherapy |
Countries
United States
Outcome results
None listed